Factors Influencing the COVID-19 Vaccine Hesitancy Across Diverse Participants Across Patients, Healthcare Providers And Common Public – A Cross Sectional Questionnaire-Based Perception Mapping Survey (Preprint)
BACKGROUND Vaccine hesitancy is refusal or reluctance in the acceptance of vaccination despite the availability of vaccination services OBJECTIVE Understanding determinants of vaccine hesitancy for early identification of vaccine concerns to analyse acceptance behaviour in public and in healthcare providers for recommendation behaviour. Target population would be across multiple cities in India, Indonesia, UAE and UK METHODS Questions for survey would be corroborative with existing tools for vaccine hesitancy, based on PICO statement incorporating public health mistrust scale, perceived COVID-19 societal stigma scale - adapted from perceived external stigma of Ebola-related stigma questionnaire, COVID-19-related prosocial behaviors adapted from two scales: empathic responding to SARS scale and pro socialness scale. Time duration from first whatsapp communication, three reminders and execution per targeted individual participant would be for 10 days. Target population include, patients visiting multi-specialty hospital in urban and rural setting in India, physicians in clinical practice across country including corona warriors involved in front-end, university students in medical school, pharmacists in pharmaceutical trade RESULTS We would identify sources of vaccine misinformation, analyse patterns of spread of inaccurate information and help flatten the curve of infodemic. This would enable to define a vaccine confidence index for determining customised educational intervention to support percolation of evidence-based information for COVID-19 vaccine to remove unscientific barriers preventing the uptake and acceptance of the COVID-19 vaccine. This would enhance health care provider's confidence in recommending vaccination and thus increasing coverage rates. We plan to submit research work to speciality conferences and plan to conduct workshops to develop educational materials which to mitigate the COVID-19 vaccine hesitancy CONCLUSIONS We would explore gaps to build scientific trust in era of scientific uncertainty when politicians rather than the medical experts have become the public faces of crisis management CLINICALTRIAL NA